Ksiazek Thomas G, Erdman Dean, Goldsmith Cynthia S, Zaki Sherif R, Peret Teresa, Emery Shannon, Tong Suxiang, Urbani Carlo, Comer James A, Lim Wilina, Rollin Pierre E, Dowell Scott F, Ling Ai-Ee, Humphrey Charles D, Shieh Wun-Ju, Guarner Jeannette, Paddock Christopher D, Rota Paul, Fields Barry, DeRisi Joseph, Yang Jyh-Yuan, Cox Nancy, Hughes James M, LeDuc James W, Bellini William J, Anderson Larry J
Special Pathogens Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA.
N Engl J Med. 2003 May 15;348(20):1953-66. doi: 10.1056/NEJMoa030781. Epub 2003 Apr 10.
A worldwide outbreak of severe acute respiratory syndrome (SARS) has been associated with exposures originating from a single ill health care worker from Guangdong Province, China. We conducted studies to identify the etiologic agent of this outbreak.
We received clinical specimens from patients in seven countries and tested them, using virus-isolation techniques, electron-microscopical and histologic studies, and molecular and serologic assays, in an attempt to identify a wide range of potential pathogens.
None of the previously described respiratory pathogens were consistently identified. However, a novel coronavirus was isolated from patients who met the case definition of SARS. Cytopathological features were noted in Vero E6 cells inoculated with a throat-swab specimen. Electron-microscopical examination revealed ultrastructural features characteristic of coronaviruses. Immunohistochemical and immunofluorescence staining revealed reactivity with group I coronavirus polyclonal antibodies. Consensus coronavirus primers designed to amplify a fragment of the polymerase gene by reverse transcription-polymerase chain reaction (RT-PCR) were used to obtain a sequence that clearly identified the isolate as a unique coronavirus only distantly related to previously sequenced coronaviruses. With specific diagnostic RT-PCR primers we identified several identical nucleotide sequences in 12 patients from several locations, a finding consistent with a point-source outbreak. Indirect fluorescence antibody tests and enzyme-linked immunosorbent assays made with the new isolate have been used to demonstrate a virus-specific serologic response. This virus may never before have circulated in the U.S. population.
A novel coronavirus is associated with this outbreak, and the evidence indicates that this virus has an etiologic role in SARS. Because of the death of Dr. Carlo Urbani, we propose that our first isolate be named the Urbani strain of SARS-associated coronavirus.
严重急性呼吸综合征(SARS)在全球范围内的爆发与一名来自中国广东省的患病医护人员的接触有关。我们开展了研究以确定此次疫情的病原体。
我们从七个国家的患者那里获取了临床标本,并使用病毒分离技术、电子显微镜和组织学研究以及分子和血清学检测方法对其进行检测,试图识别多种潜在病原体。
之前描述的呼吸道病原体均未被一致识别出来。然而,从符合SARS病例定义的患者中分离出了一种新型冠状病毒。在用咽喉拭子标本接种的Vero E6细胞中观察到了细胞病理学特征。电子显微镜检查揭示了冠状病毒的超微结构特征。免疫组织化学和免疫荧光染色显示与I组冠状病毒多克隆抗体有反应性。设计用于通过逆转录 - 聚合酶链反应(RT-PCR)扩增聚合酶基因片段的通用冠状病毒引物被用来获得一个序列,该序列明确将该分离株鉴定为一种仅与先前测序的冠状病毒有远缘关系的独特冠状病毒。使用特异性诊断RT-PCR引物,我们在来自几个地点的12名患者中鉴定出了几个相同的核苷酸序列,这一发现与点源爆发一致。用新分离株进行的间接荧光抗体试验和酶联免疫吸附试验已被用于证明病毒特异性血清学反应。这种病毒可能此前从未在美国人群中传播过。
一种新型冠状病毒与此次疫情有关,证据表明该病毒在SARS中具有病因学作用。由于卡洛·乌尔巴尼医生去世,我们提议将我们的首个分离株命名为SARS相关冠状病毒的乌尔巴尼株。